The Tubulin Alpha 4a (TUBA4A) gene has been recently associated with amyotrophic lateral sclerosis. Interestingly, some of the mutation carriers were also diagnosed with frontotemporal degeneration (FTD) or mild cognitive impairment. With the aim to investigate the role of TUBA4A in FTD, we screened TUBA4A in a series of 814 FTD patients from Spain. Our data did not disclose any nonsense or missense variant in the cohort, thus suggesting that TUBA4A mutations are not associated with FTD.
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
. Recently, a case-control study found an excess of rare damaging variants in Tubulin Alpha 4a (TUBA4A) gene in familial ALS index cases using an exome-sequencing method (Smith et al. 2014) . Importantly, among the seven ALS patients carrying rare variants in TUBA4A, two of them developed FTD and one had a first-degree relative affected by FTD. The involvement of TUBA4A in ALS has been recently replicated in a cohort of sporadic ALS patients (Pensato et al., 2015) .
Notably, one of the four mutation carriers had mild cognitive impairment. Overall, these data suggest that TUBA4A mutations might be particularly associated with the FTD-ALS disease continuum. Here we test this hypothesis in a large series of FTD patients from Spain. TUBA4A and a concomitant presence of ALS in FTD, with the proviso that the limited subset of cases (n=31) available to us limits any firm conclusion and warrants further studies in larger cohorts of patients manifesting these two devastating disorders. 
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